An experimental drug for sepsis now in human clinical trials
A new experimental drug to treat sepsis has now entered the next stage of clinical trials in patients in Australia...
A new experimental drug to treat sepsis has now entered the next stage of clinical trials in patients in Australia...
From Phase 1 human trials for a Malaria vaccine, to studies aimed at treating osteoporosis and a number of trials into innovative life-saving stroke treatment, the Gold Coast Health & Knowledge Precinct is fast gaining a reputation as a leading location for clinical trials.
Development of a vaccine that can treat the bacteria which causes Scarlet Fever and can lead to rheumatic fever, has the potential to save the lives of many Indigenous Australians and other lives worldwide.
A Phase I human clinical trial is set to commence to test the efficacy and safety of the transplantation of olfactory cell nerve bridges to treat chronic spinal cord injury.
The first-ever adaptive clinical trial for Australians living with MS will seek to reverse neurological damage caused by progressive multiple sclerosis.
The Institute for Glycomics’ malaria vaccine researchers are one step closer to human trials for a malaria vaccine that can be freeze-dried.
Griffith University’sClinical Trials Unit is the first globally to recruit patients for a multi-national rheumatology trial, and will also screen the first patient in Australia for a Meningococcal vaccine trial.
A $2million grant from Cancer Council of Queensland will help Griffith researchers continue vital work in bolstering survival rates in women treated for ovarian cancer.
Human clinical trial success of new drug candidate to treat viral arthritis caused by mosquito-borne infections.
Researchers offer free trials to help reduce burden of osteoporotic fractures in older women.